Biopharmaceutical giant AbbVie Inc., represented by Kirkland & Ellis, has struck a $63 billion deal to acquire Irish pharmaceutical firm Allergan, with a legal team led by Wachtell, Lipton, Rosen & Katz.

While Kirkland has handled litigation work for AbbVie, this is the first time Kirkland has advised the client in a major transaction. Kirkland’s corporate partners on the deal include Eric Schiele, Jonathan Davis and Carlo Zenkner. Kirkland recruited Schiele and Davis from Cravath, Swaine & Moore in 2018 and 2016, respectively, while adding Zenkner, who was a Sullivan & Cromwell associate, in 2017.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]